Active substance

Results for the substance formoterol glycopyrronium budesonide

2 results

About this active substance

Formoterol, glycopyrronium, and budesonide are three active substances combined in a single inhaler, used for the treatment of chronic obstructive pulmonary disease (COPD) and, in some cases, severe asthma. Formoterol is a fast-acting, long-lasting bronchodilator, glycopyrronium is an anticholinergic that relaxes the airway muscles, and budesonide is a corticosteroid that reduces inflammation in the lungs.

This combination medication is administered by inhalation, usually once or twice daily, as directed by your doctor. Regular use helps keep symptoms under control, reduces breathing crises, and improves the quality of life for patients with chronic respiratory conditions.

Side effects may include throat irritation, hoarseness, oral fungal infections, palpitations, or dry mouth. To reduce the risk of oral infections, it is recommended to rinse your mouth after each use. If you experience severe or unusual reactions, contact your doctor immediately.

Formoterol, glycopyrronium, and budesonide provide an effective solution for long-term management of COPD and severe asthma, but the treatment must be followed strictly according to medical recommendations. Do not change the dose or stop treatment without your specialist's approval.